Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
5 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Rafael Holdings, Inc.’s names, not what it holds today.
Patents granted
5
5 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 2 in 2024 and none in 2023
Applications published
11
2 of them in 2025
Names they are printed under
5
a subsidiary, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
LIPOMEDIX PHARMACEUTICALS LTD. a subsidiary
named as the applicant on its applications, in IL
6 publishedLipomedix Pharmaceuticals Ltd. a subsidiary
IL, as the owner printed on each patent
0 publishedCyclo Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
3 publishedRAFAEL HOLDINGS, INC. its own name
US, as the owner printed on each patent
2 publishedCyclo Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 24, 2024 | 12,171,746 | Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture | Pharmaceuticals | Lipomedix Pharmaceuticals Ltd. |
| Mar 12, 2024 | 11,925,659 | Methods for treating Alzheimer's disease | Pharmaceuticals | Cyclo Therapeutics, Inc. |
| Apr 14, 2020 | 10,617,672 | Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C | Pharmaceuticals | Lipomedix Pharmaceuticals Ltd. |
| Sep 25, 2018 | 10,080,807 | Combination chemotherapy comprising a liposomal prodrug of mitomycin C | Pharmaceuticals | Lipomedix Pharmaceuticals Ltd. |
| Apr 10, 2018 | 9,937,261 | Combination therapy comprising a liposomal prodrug of mitomycin C and radiotherapy | Pharmaceuticals | Lipomedix Pharmaceuticals Ltd. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 2, 2025 | 2025/0302864 | METHODS FOR TREATING ALZHEIMER’S DISEASE | Pharmaceuticals | Cyclo Therapeutics, Inc. |
| Feb 27, 2025 | 2025/0064784 | LIPOSOME COMPOSITION COMPRISING LIPOSOMAL PRODRUG OF MITOMYCIN C AND METHODS OF TREATMENT | Pharmaceuticals | LIPOMEDIX PHARMACEUTICALS LTD. |
| Dec 19, 2024 | 2024/0415871 | METHODS FOR TREATING ALZHEIMER’S DISEASE | Pharmaceuticals | Cyclo Therapeutics, Inc. |
| Nov 3, 2022 | 2022/0346627 | VIDEOSCOPIC ARTHROSCOPIC INSTRUMENTS, DEVICES, AND SYSTEMS AND METHODS OF USE AND ASSEMBLY | Medical technology | RAFAEL HOLDINGS, INC. |
| Jul 21, 2022 | 2022/0226100 | COMPRESSION ANCHOR SYSTEMS, DEVICES, INSTRUMENTS, IMPLANTS AND METHODS OF ASSEMBLY AND USE | Medical technology | RAFAEL HOLDINGS, INC. |
| Mar 24, 2022 | 2022/0087975 | LIPOSOME COMPOSITION COMPRISING LIPOSOMAL PRODRUG OF MITOMYCIN C AND METHOD OF MANUFACTURE | Pharmaceuticals | LIPOMEDIX PHARMACEUTICALS LTD. · patent 12,171,746 granted from it |
| Jan 13, 2022 | 2022/0008453 | METHODS FOR TREATING ALZHEIMER'S DISEASE | Pharmaceuticals | Cyclo Therapeutics, Inc. · patent 11,925,659 granted from it |
| Oct 18, 2018 | 2018/0296529 | LIPOSOME COMPOSITION CO-ENCAPSULATING DOXORUBICIN AND A PRODRUG OF MITOMYCIN C | Pharmaceuticals | LIPOMEDIX PHARMACEUTICALS LTD. · patent 10,617,672 granted from it |
| Mar 15, 2018 | 2018/0071253 | METHODS FOR THE TREATMENT OF BLADDER CANCER | Pharmaceuticals | LIPOMEDIX PHARMACEUTICALS LTD. |
| May 4, 2017 | 2017/0119895 | COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY | Pharmaceuticals | LIPOMEDIX PHARMACEUTICALS LTD. · patent 9,937,261 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 3.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.